课题基金 / 基金详情

PAD2 and CitH3 in Pathogenesis of Sepsis-induced ALI

PAD2 and CitH3 in Pathogenesis of Sepsis-induced ALI
PAD2 和 CitH3 在脓毒症引起的 ALI 发病机制中的作用
批准号:
10293158
负责人:
HASAN B ALAM
金额:
$53.4万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2025-08-31

项目摘要

项目成果

HASAN B ALAM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY ABSTRACT Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection, and acute lung injury (ALI) is a leading cause of death associated with sepsis. An emerging mechanism of sepsis induced-ALI (sepsis-ALI) involves neutrophils/macrophages undergoing cell death, releasing nuclear histones and citrullinated histone H3 (CitH3) to cause tissue damage and exacerbate pulmonary injury. CitH3 is catalyzed by peptidylarginine deiminase 2 and 4 (PAD2 and PAD4). We found that CitH3 is elevated in serum of patients with sepsis-ALI, but not in ALI patients due to non-infectious causes, suggesting that CitH3 could be a biomarker, as well as a potential causative factor for sepsis-ALI. Significant elevations of CitH3 and PAD2 in bronchoalveolar lavage fluid (BALF), not PAD4, are detected in septic patients. While Pad4-/- mice do not show a clear septic phenotype compared with wild type littermates, the Pad2-/- mice are strikingly more resistant to sepsis-ALI and other organ dysfunctions. The improved survival of the Pad2-/- septic mice is linked to enhanced bacterial clearance due to enhanced function of macrophages. We have data to show that chemical inhibition of PAD2 and antibody sequestration of CitH3 have therapeutic benefits to treat sepsis- ALI in mice. Combining our expertise in cell and molecular biology, animal models of and clinical research in sepsis, and chemical biology, our team-based research aims to dissect the physiological actions of PAD2 and CitH3 in modulating macrophage function associated with sepsis (Aim 1), and to conduct proof-of-concept studies targeting PAD2 and CitH3 as novel means to treat sepsis-ALI in mice (Aim 2). Circulating CitH3 could act as a signaling molecule and bind to membrane receptor(s) to fulfill its biological function; or CitH3 can enter the host cells via endocytosis to directly interfere with their survival or death pathways. Thus, knowledge on the membrane delimited interaction between CitH3 and macrophages will add significant insight into the pathogenesis and potential treatment of sepsis-ALI and other multi-organ dysfunctions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PAD2 and CitH3 in Pathogenesis of Sepsis-induced ALI
PAD2 and CitH3 in Pathogenesis of Sepsis-induced ALI
Modulation of Acetylation in the Treatment of Lethal Hemorrhagic Shock
  • 批准号:
    7805621
  • 项目类别:
  • 资助金额:
    $32.63万
  • 财政年份:
    2009
  • 负责人:
    HASAN B ALAM
  • 依托单位:
Modulation of Acetylation in the Treatment of Lethal Hemorrhagic Shock
  • 批准号:
    8245755
  • 项目类别:
  • 资助金额:
    $8.98万
  • 财政年份:
    2009
  • 负责人:
    HASAN B ALAM
  • 依托单位:
海外基金